Data Bridge Market Research analyzes that the calcineurin inhibitors market which was USD 9.08 billion in 2022, would rocket up to USD 20.47 billion by 2030, and is expected to undergo a CAGR of 10.7% during the forecast period. Calcineurin inhibitors are drugs that stop calcineurin from working. Calcineurin is an enzyme that activates immune system T-cells. T-cells (also known as...